Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) Granted CE Mark For Agent Drug-Coated Balloon

July 23, 2014 5:15 PM
Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles